semaglutide after kidney transplant and Ozempic-like drugs may improve disease outcomes Obesity management for kidney TRANSPLANTation

Garfinkel, D., Zisapel, N., Wainstein, J., & Laudon, M

euglycemic diabetic ketoacidosis is often overlooked because of the absence of hyperglycemia

Eli Lilly: Tirzepatide/Mounjaro Lily initially developed Tirzepatide as a dual agonist, with a half-life of around 5 days, for the treatment of T2DM

Dizziness can be a sign that your blood pressure has dropped too low or that you are becoming dehydrated

This pharmacovigilance system is crucial for identifying previously unrecognised adverse effects, monitoring the safety profile of newly licensed medications like Mounjaro, and detecting rare but serious reactions that may not have been apparent during clinical trials

Several studies have explored this new application, focusing on how semaglutide might help asthma patients